Banner for leaf pages 2

Pramlintide (Symlin)

Also known as Symlin

Pramlintide (Symlin) is a relatively new adjunct for diabetes (both type 1 and 2), developed by Amylin Pharmaceuticals (now a wholly owned subsidiary of Bristol Myers-Squibb). Pramlintide is delivered as an acetate salt.

Source: Wikipedia

Estimated Total Cost: $472.24 for an average of 28 days supply

What is it prescribed for?

Patients are most commonly prescribed pramlintide to treat diabetes, hyperlipidemia, hypothyroidism, and rabies.

What drug interactions are known?

Do not take pramlintide if you are taking any of the following:

Critical Interactions

Significant Interactions

What side effects are related?

Patients taking pramlintide most commonly experience side effects like nausea, headache, and vomiting.

Ajax-loader Loading...